SEC Comment Letter for TANDEM DIABETES CARE INC (TNDM) (CIK 0001438133) (TNDM) — Mar 15, 2017
TANDEM DIABETES CARE INC (TNDM) (CIK 0001438133)
Date: March 15, 2017 · CIK: 0001438133 · Accession: 0000000000-17-008485
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-216531
Letter
Mail Stop 3030 March 1 4, 2017 Via E -mail Kim D. Blickenstaff President and Chief Executive Officer Tandem Diabetes Care, Inc. 11045 Roselle Street San Diego, CA 92121
Re: Tandem Diabetes Care, Inc. Registration Statement on Form S-1 Filed March 8, 2017 File No. 333-216531
Dear Mr. Blickenstaff :
This is to advise you that we have not reviewed and will not review your registration statement .
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Caleb French at (202) 551 -6947 with any questions.
Sincerely,
/s/ Caleb French for
Show Raw Text
Mail Stop 3030 March 1 4, 2017 Via E -mail Kim D. Blickenstaff President and Chief Executive Officer Tandem Diabetes Care, Inc. 11045 Roselle Street San Diego, CA 92121 Re: Tandem Diabetes Care, Inc. Registration Statement on Form S-1 Filed March 8, 2017 File No. 333-216531 Dear Mr. Blickenstaff : This is to advise you that we have not reviewed and will not review your registration statement . Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Caleb French at (202) 551 -6947 with any questions. Sincerely, /s/ Caleb French for Amanda Ravitz Assistant Director Office of Electronics and Machinery cc: Ryan C. Wilkins , Esq. Stradling Yocca Carlson & Rauth, P.C.